Recursion Pharmaceuticals Ownership | Who Owns Recursion Pharmaceuticals?
Recursion Pharmaceuticals Ownership Summary
Recursion Pharmaceuticals is owned by 77.62% institutional investors, 3.94% insiders, and 18.44% retail investors. Vanguard group is the largest institutional shareholder, holding 9.53% of RXRX shares. ARK Innovation ETF is the top mutual fund, with 4.19% of its assets in Recursion Pharmaceuticals shares.
RXRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Recursion Pharmaceuticals | 77.62% | 3.94% | 18.44% |
| Sector | Healthcare Stocks | 42.57% | 10.84% | 46.59% |
| Industry | Biotech Stocks | 45.28% | 10.77% | 43.95% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 39.78M | 9.53% | $194.13M |
| Ark investment management | 33.55M | 8.04% | $163.70B |
| Blackrock funding, inc. /de | 31.74M | 7.60% | $154.89M |
| Blackrock | 17.31M | 7.33% | $129.83M |
| Baillie gifford | 23.98M | 5.75% | $117.02B |
| State street | 18.27M | 4.38% | $89.15M |
| Softbank group | 14.67M | 3.51% | $71.58M |
| Kinnevik ab (publ) | 13.43M | 3.22% | $65.56M |
| Mubadala investment co pjsc | 12.99M | 3.11% | $63.37M |
| Mic capital management uk llp | 9.64M | 2.31% | $47.06M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Kinnevik ab (publ) | 13.43M | 100.00% | $65.56M |
| Dcvc opportunity fund ii gp | 3.95M | 100.00% | $19.28M |
| Data collective iv gp | 5.94M | 42.65% | $28.99M |
| Mic capital management uk llp | 9.64M | 9.41% | $47.06M |
| Nan fung group | 595.29K | 4.87% | $2.91M |
| Novo | 7.93M | 2.49% | $38.70M |
| Pivotal bioventure partners investment advisor | 595.52K | 1.68% | $2.91M |
| Green alpha advisors | 212.20K | 1.00% | $1.04M |
| Nvidia | 7.71M | 0.98% | $37.61M |
| Ark investment management | 33.55M | 0.97% | $163.70B |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 18.27M | 0.00% | 7.09M |
| Blackrock | 17.31M | 0.00% | 4.99M |
| Vanguard group | 39.78M | 0.00% | 3.71M |
| Norges bank | 3.47M | 0.00% | 3.47M |
| Blackrock funding, inc. /de | 31.74M | 0.00% | 3.37M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -7.73M |
| Fmr | 3.23M | 0.00% | -2.36M |
| Deerfield management company, l.p. (series c) | - | - | -2.31M |
| Novo | 7.93M | 2.49% | -1.74M |
| Pictet & cie (europe) sa | - | - | -1.63M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 3.47M | 0.00% | 3.47M | $23.43M |
| Jane street group | 721.55K | 0.00% | 721.55K | $3.52B |
| American century companies | 316.18K | 0.00% | 316.18K | $1.54M |
| Trexquant investment lp | 228.75K | 0.01% | 228.75K | $1.12M |
| Verity asset management | 99.34K | 0.16% | 99.34K | $484.76K |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -1.00 |
| Nbc securities | -1.00 |
| Twin peaks wealth advisors | -4.00 |
| Financial gravity asset management | -4.00 |
| Householder group estate & retirement specialist | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 331 | -6.76% | 323,965,396 | 4.44% | 77 | 1.41% | 170 | -3.41% | 78 | -8.24% |
| Jun 30, 2025 | 341 | -2.01% | 308,955,617 | 7.04% | 74 | 1.44% | 170 | -16.67% | 85 | 21.43% |
| Mar 31, 2025 | 350 | 4.79% | 304,203,724 | -0.17% | 75 | 0.65% | 204 | 2.51% | 72 | 14.29% |
| Dec 31, 2024 | 308 | 10.79% | 289,638,352 | 11.01% | 102 | 1.20% | 181 | 16.77% | 56 | 12.00% |
| Sep 30, 2024 | 275 | -1.43% | 260,863,978 | 3.59% | 92 | 0.81% | 154 | -13.97% | 49 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Innovation ETF | 18.29M | 4.19% | -280.38K |
| ARK Disruptive Innovation Full Composite | 18.19M | 4.19% | -1.10M |
| Scottish Mortgage Ord | 18.17M | 4.19% | - |
| Vanguard Total Stock Mkt Idx Inv | 12.16M | 2.80% | -259.15K |
| ARK Genomic Revolution | 11.44M | 2.63% | -1.17M |
| ARK Genomic Revolution ETF | 11.42M | 2.62% | -40.75K |
| Vanguard Small Cap Index | 9.22M | 2.12% | -56.27K |
| Vanguard US Total Market Shares ETF | 8.01M | 1.99% | 1.01M |
| iShares Russell 2000 ETF | 8.18M | 1.87% | - |
| Vanguard Small Cap Growth Index Inv | 5.21M | 1.20% | -1.90K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 20, 2026 | Gibson Christopher | - | Sell | $178.80K |
| Jan 06, 2026 | Borgeson Blake | - | Sell | $959.20K |
| Jan 05, 2026 | Gibson Christopher | - | Sell | $170.00K |
| Dec 29, 2025 | Taylor Ben R | Chief Financial Officer | Sell | $89.38K |
| Dec 22, 2025 | Khan Najat | Chief R&D Commercial Officer | Sell | $548.59K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 3 |
| 2025 Q4 | - | 9 |
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | 7 |
RXRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools